✦ LIBER ✦

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

✍ Scribed by Mihai Gheorghiade; Cesare Orlandi; John C. Burnett Jr.; David DeMets; Liliana Grinfeld; Aldo Maggioni; Karl Swedberg; James E. Udelson; Faiez Zannad; Christopher Zimmer; Marvin A. Konstam

Book ID: 119212844
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 147 KB
Volume: 11
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2005.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and study design for a multice

Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure

✍ Mihai Gheorghiade; Wendy A. Gattis; Alejandro Barbagelata; Kirkwood F. Adams Jr; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A Multicenter, Randomized, Double-blind,

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction

✍ James E. Udelson; Martin Bilsker; Paul J. Hauptman; Rafael Sequeira; Ignatius Th 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Multicenter, randomized, placebo-control

Multicenter, randomized, placebo-controlled, double-blind study of the safety and efficacy of oral delapril in patients with congestive heart failure

✍ Antonio Circo; Francesco Platania; Salvatore Mangiameli; Ernesto Putignano 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 764 KB

Effects of tolvaptan on physician-assess

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

✍ Peter S. Pang; Mihai Gheorghiade; Jamil Dihu; Karl Swedberg; Sadiya Khan; Aldo P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Continental Differences in Clinical Char

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program

✍ John E.A. Blair; Faiez Zannad; Marvin A. Konstam; Thomas Cook; Brian Traver; Joh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Multicenter, Randomized, Double-Blind, P

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction

✍ James E. Udelson; Frank A. McGrew; Enrique Flores; Hassan Ibrahim; Stewart Katz; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 519 KB